Form 4: Twist Bioscience Corp: Executive Robert F. Werner Reports Stock Transactions

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, reports acquisition of 8,500 shares and sale of 156 shares to cover tax obligations.

Summary

• On November 4, 2024, Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, acquired 8,500 shares of common stock due to the vesting of performance stock units (PSUs).
• 60% of these PSUs will vest on October 1, 2025, subject to continued service.
• Werner also sold 156 shares on November 4, 2024, at a price of $41.564 per share to cover tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, Werner beneficially owns 47,068 shares of Twist Bioscience Corp.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions are related to compensation and tax obligations, with no clear indication of positive or negative sentiment regarding the company's future.

Positives

• The vesting of performance stock units suggests that performance targets were met.

Negatives

• The sale of shares to cover tax obligations, while not discretionary, could be perceived negatively by some investors.

Risks

• Future vesting of PSUs is contingent on continued service, introducing a potential risk if Werner were to leave the company.

Future Outlook

60% of the performance stock units will vest on October 1, 2025, contingent on continued service.

Industry Context

Tracking insider transactions provides insights into management's perspective on the company's valuation and future prospects within the synthetic biology industry. This is a routine filing and doesn't necessarily indicate a major shift in the company's outlook.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in the biotech industry, similar to companies like Ginkgo Bioworks (DNA) and Amyris (AMRS) before its delisting.
• The 'sell to cover' practice for tax obligations is standard across many publicly traded companies.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as the number of shares involved is relatively small compared to the total outstanding shares.

Key Dates